Clinical efficacy and safety: cardiovascular system
The European Medicines Agency's scientific guidelines on the clinical evaluation of human medicines used in conditions affecting the cardiovascular system help medicine developers prepare marketing authorisation applications.
If you have comments on a document which is open for consultation, use the .
Please submit your comments to the following email address: cvswpsecretariat@ema.europa.eu.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.
- Hypertension
- Lipid disorders
- Pulmonary arterial hypertension
- Arrythmias
- Venous thromboembolism
- Heart failure
- Coronary artery disease (CAD)
- Other
Hypertension
Lipid disorders
Pulmonary arterial hypertenstion
Arrythmias
Venous thromboembolism
Heart failure
Coronary artery disease
Other
Position statements